Testimonials

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Catalogue

Register

Privileged Access Section

Antibody Catalogue - R

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Antigen Clone
Rab11a STo 2F3
Rab11a Sto 7C10
Rad17 Rad17 1C6/2
Rad24 Polyclonal
Rad51 Rad51 3C10
Rad51 Polyclonal SWE26
Rad51B Rad51B 1E11/6
Rad51B rad51b 1h3/13
Rad51C Rad51C 2H11/6
Rad51C polyclonal 3R68
Rad51D Rad51D 5A8/4
Rad51D Rad51D 5B3/6
Rad52 Polyclonal FBE3
Rad54 Rad54 4E3/1
RAP1 RAP1 4C8/1
RecA Polyclonal SWE8
Retinoblastoma (Rb1) Rb1
RNA pol II CTD 4H8
RNA pol II (phospho) CTD 8A7
Rough Endoplasmic Reticulum Component BU18
RuvA RuvA 12C6
RuvA Polyclonal SWE2
RuvB RuvB 4G5/1
RuvB Polyclonal SWE4
RuvC RuvC 5G9/3
RuvC RuvC 7F1/5
RuvC Polyclonal SWE6
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only.  However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.